A single dose pharmacokinetic and safety study of COL 1077 in healthy volunteers

Trial Profile

A single dose pharmacokinetic and safety study of COL 1077 in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jan 2017

At a glance

  • Drugs Lidocaine (Primary)
  • Indications Dysmenorrhoea; Pain
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 01 Jan 2017 Results from this and other trial (see profile 18141) published in the Clinical Pharmacology in Drug Development
    • 07 Jul 2016 Combined results from this and another phase I trial (CTP 700018141) published in a Juniper Pharmaceuticals media release.
    • 16 Jun 2016 Results published in a Juniper Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top